These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2976598)

  • 1. [The demand for the main cardiovascular preparations in the city of Frunze].
    Golubeva IV; Kal'ko TF; Ruppa IaM; Bektenova GZ; Tenenbaum AM
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1988; 11(2):93-6. PubMed ID: 2976598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescription of cardiovascular drugs in outpatient care: a survey of outpatients in a German university hospital.
    Harder S; Thürmann P; Thierolf C; Klepzig H
    Int J Clin Pharmacol Ther; 1998 Apr; 36(4):195-201. PubMed ID: 9587045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic obstructive pulmonary disease and coronary heart disease: approaches to the treatment of combined pathology].
    Bova AA; Lapitskiĭ DV
    Klin Med (Mosk); 2009; 87(2):8-13. PubMed ID: 19348292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The surgical and drug treatment of ischemic heart disease].
    Knyshov GV; Vykhovaniuk IV
    Vrach Delo; 1991 Feb; (2):23-7. PubMed ID: 2058114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey of outpatient management of elderly heart failure patients in Poland-treatment patterns.
    Rywik TM; Rywik SL; Korewicki J; Broda G; Sarnecka A; Drewla J
    Int J Cardiol; 2004 Jun; 95(2-3):177-84. PubMed ID: 15193817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy in patients with stable coronary artery disease treated on an outpatient basis in Poland. Results of the multicentre RECENT study.
    Banasiak W; Wilkins A; Pociupany R; Ponikowski P
    Kardiol Pol; 2008 Jun; 66(6):642-9; discussion 650. PubMed ID: 18626833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium-antagonists in ischemic heart disease.
    Schaefer J
    Arch Inst Cardiol Mex; 1980; 50(3):289-93. PubMed ID: 7425746
    [No Abstract]   [Full Text] [Related]  

  • 8. [Actual and theoretical points of view in the application of coronary therapeutic agents].
    Döring D
    Z Gesamte Inn Med; 1980 Jun; 35(11):475-81. PubMed ID: 6108022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of MONIKA on the utilization of cardiovascular drugs in districts where the system is used].
    Stika L; Fikr V; Komárková V
    Cesk Zdrav; 1990 Dec; 38(12):537-44. PubMed ID: 2285957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heart failure in the practice of primary health care in Kemerovo].
    Nesterova YI; Bondareva IN; Ovchinnikova VV
    Ter Arkh; 2007; 79(1):15-8. PubMed ID: 17385457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999.
    Critchley J; Liu J; Zhao D; Wei W; Capewell S
    Circulation; 2004 Sep; 110(10):1236-44. PubMed ID: 15337690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of use of cardiovascular drugs in 499 patients with suspected coronary artery disease at time of hospitalization for coronary angiography and in 357 patients with obstructive coronary artery disease documented by coronary angiography.
    Mazar M; Schair B; Aronow WS; Khalique O; Lehrman SG
    Am J Ther; 2008; 15(5):458-60. PubMed ID: 18806522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical therapy in patients undergoing percutaneous coronary intervention: results from the ROSETTA registry.
    Eisenberg MJ; Okrainec K; Lefkovits J; Goudreau E; Deligonul U; Mak KH; Duerr R; Tsang J; Huynh T; Sedlis S; Brown DL; Brieger D; Pilote L;
    Can J Cardiol; 2003 Aug; 19(9):1009-15. PubMed ID: 12915928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Large scale multicenter cooperative study for cardiovascular therapy (Japan Multicenter Investigation for Cardiovascular Drugs/Therapies, J-MIC)--results and perspectives].
    Kawai C; Yui Y; Hosoda S
    Nihon Rinsho; 1994 Jul; 52(7):1937-46. PubMed ID: 8078206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular drugs and dental considerations.
    Wynn RL
    J Calif Dent Assoc; 2000 Jul; 28(7):519-26. PubMed ID: 11324134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular drugs in Czechoslovakia--registration and consumption data.
    Seflová M; Sechser T; Strnadová J; Skop B; Váchová M; Svihovec J
    Pol J Pharmacol Pharm; 1989; 41(6):533-7. PubMed ID: 2485903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of generic cardiovascular medications by elderly Medicare beneficiaries receiving generalist or cardiologist care.
    Federman AD; Halm EA; Siu AL
    Med Care; 2007 Feb; 45(2):109-15. PubMed ID: 17224772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differential therapeutic aspects in the use of drugs that reduce preload and/or afterload in coronary heart disease].
    Klaus W; Bassenge E; Böhme E; Drebinger K; Gilfrich HJ; Grewe R; Hellige G; Krüger R; Lossnitzer K; Simon H
    Med Klin (Munich); 1987 Jan; 1():33-8. PubMed ID: 3472030
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effectiveness of antianginal preparations in ischemic heart disease depending on the duration of the courses of treatment].
    Progonnaia VV
    Vrach Delo; 1988 Jul; (7):29-31. PubMed ID: 3188458
    [No Abstract]   [Full Text] [Related]  

  • 20. [Trends in the prescription of cardiovascular drugs in a geriatric hospital].
    Gauthey L; Karpuz H; Herrmann F; Zelger G; Michel JP
    Schweiz Med Wochenschr; 1994 Nov; 124(44):1952-4. PubMed ID: 7973525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.